Michael P Morrissey

Michael P Morrissey

Central US Merck & Co., Inc. - Kenilworth / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4376381
-
person_outline Michael P Morrissey's MOST POPULAR ARTICLES
1-) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJ Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ...Nature 483 (7391), 603, 201266572012
2-) Next-generation characterization of the Cancer Cell Line EncyclopediaM Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ...Nature 569 (7757), 503, 201915452019
3-) Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastomaS Buonamici, J Williams, M Morrissey, A Wang, R Guo, A Vattay, K Hsiao, ...Science translational medicine 2 (51), 51ra70-51ra70, 20104812010
4-) Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaEJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ...Nature medicine 24 (10), 1504, 20184972018
5-) Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphomaR Rahal, M Frick, R Romero, JM Korn, R Kridel, FC Chan, B Meissner, ...Nature medicine 20 (1), 87, 20144062014